Table 2 Comorbidity profile of total sample and by sex
|  | Total n = 195 | Women n = 159 | Men n = 36 | p-value |
|---|---|---|---|---|
n (%) | n (%) | n (%) | Â | |
Sleep Apnea | 127 (65.1) | 94 (59.1) | 33 (91.7) | p < .001 |
On CPAP | 89 (70.1) | 61 (64.9) | 28 (84.8) | Â |
Back Pain (n = 188) | 95 (50.5) | 80 (51.3) | 15 (46.9) | p = 0.650 |
Dyslipidemia (n = 186) | 89 (47.8) | 68 (43.9) | 21 (67.7) | p = 0.015 |
Hypertension (n = 188) | 89 (47.3) | 67 (42.9) | 22 (68.8) | p = 0.008 |
Osteoarthritis (n = 188) | 83 (44.1) | 68 (43.6) | 15 (46.9) | p = 0.733 |
Type 2 Diabetes | 82 (42.1) | 64 (40.3) | 18 (50.0) | p = 0.285 |
Gastroesophageal Reflux Disease (n = 189) | 81 (43.1) | 64 (41.0) | 17 (53.1) | p = 0.155 |
Gallbladder Disease/Gallstones (n = 187) | 75 (40.1) | 68 (43.6) | 7 (22.6) | p = 0.029 |
Asthma (n = 188) | 42 (22.3) | 32 (20.5) | 10 (31.3) | p = 0.184 |
Polycystic Ovary Syndrome (n = 159) | 32 (20.1) | 32 (20.1) | n/a |  |
Yeast/Fungal Infection (n = 187) | 26 (13.9) | 24 (15.5) | 2 (6.3) | p = 0.169 |
Hypothyroidism (n = 187) | 21 (11.2) | 19 (12.3) | 2 (6.3) | p = 0.327 |
Gout (n = 188) | 21 (11.2) | 9 (5.8) | 12 (37.5) | p = 0.000 |